1. Phase II trial of ponatinib in patients with bevacizumab‐refractory glioblastoma. (24th August 2019) Authors: Lee, Eudocia Q.; Muzikansky, Alona; Duda, Dan G.; Gaffey, Sarah; Dietrich, Jorg; Nayak, Lakshmi; Chukwueke, Ugonma N.; Beroukhim, Rameen; Doherty, Lisa; Laub, Caroline Kane; LaFrankie, Debra; Fontana, Brittney; Stefanik, Jennifer; Ruland, Sandra; Caruso, Victoria; Bruno, Jennifer; Ligon, Keith; R... Journal: Cancer medicine Issue: Volume 8:Number 13(2019:Oct.) Page Start: 5988 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗